# James P. Lin, M.D., Inc. – FDA Inspection, Aug 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/james-p-lin-md-inc/e757db1e-9818-413c-a4c6-0b8a1b57a309
Source feed: FDA_Inspections

> FDA inspection 1247157 of James P. Lin, M.D., Inc., August 22, 2024. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 1271. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247157
- Company Name: James P. Lin, M.D., Inc.
- Inspection Date: 2024-08-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1120143 - 2020-03-05](https://www.keypedia.com/records/fda_inspections/james-p-lin-md-inc/a2ea2f03-54aa-4b55-80a5-4d20da634552)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)

Company: https://www.keypedia.com/companies/james-p-lin-md-inc/b180b349-824b-4a17-b778-d3dcbf062120

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d